Ra Pharmaceuticals, Inc.
(NASDAQ : RARX)

( )
RARX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
1.66%132.070.6%$1235.92m
PFEPfizer Inc.
1.51%36.280.8%$1124.97m
ABBVAbbVie, Inc.
1.10%118.852.1%$1064.85m
MRKMerck & Co., Inc.
0.57%54.880.6%$759.52m
BMYBristol-Myers Squibb Company
3.05%67.951.4%$680.68m
LLYEli Lilly and Company
2.03%78.761.0%$495.91m
AZNAstraZeneca PLC Sponsored ADR
0.97%34.021.3%$179.46m
GSKGlaxoSmithKline plc Sponsored ADR
0.75%36.850.2%$168.65m
NVSNovartis AG Sponsored ADR
0.15%85.330.2%$162.03m
NVONovo Nordisk A/S Sponsored ADR Class B
1.63%53.930.1%$115.03m
SNYSanofi Sponsored ADR
0.80%40.170.2%$103.65m
LCILannett Company, Inc.
-4.23%15.8538.1%$13.07m
AKTXAkari Therapeutics Plc Sponsored ADR
-8.64%2.012.2%$0.42m
EPIXESSA Pharma Inc
-0.52%0.190.0%$0.03m

Company Profile

Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of next-generation therapeutics for complement-mediated diseases. It leverages a platform under the Extreme Diversity trademark to develop a portfolio of products that inhibit the complement system and other immune targets. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.